Читать книгу Applied Biostatistics for the Health Sciences - Richard J. Rossi - Страница 27

In the article “Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial” published in Archives of General Psychiatry (Furey et al., 2006), the authors reported the results of a double-blind, placebo-controlled, dose finding clinical trial designed to investigate the antidepressant efficacy of scopolamine. This study consisted of n = 19 currently depressed outpatients aged 18–50 years with recurrent major depressive disorder or bipolar disorder.